Lewis Hassell to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications Lewis Hassell has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
1.064
-
Efficacy and Safety of Crizotinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with ROS1 Rearrangement or MET Alteration: A Systematic Review and Meta-Analysis. Target Oncol. 2020 10; 15(5):589-598.
Score: 0.654
-
Performance validation in anatomic pathology: successful integration of a new classification system into the practice setting using the updated lung non-small cell carcinoma recommendations. Arch Pathol Lab Med. 2014 Jan; 138(1):105-9.
Score: 0.410